Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Frank F.R. Daelemans has worked on the following 30 EPO patent applications which have been published in the last five years:

EP12712666

PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS

IPC classification:
A61K 31/505, A61K 31/506, C07D 239/48, C07D 401/12, C07D 403/12, C07D 405/12, C07D 413/12, C07D 471/04
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, Johnson & Johnson Belgium
Status:
EXAMINATION IN PROGRESS
EP12721852

QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES

IPC classification:
A61K 31/517, A61P 31/00, C07D 239/95
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, Johnson & Johnson Belgium
Status:
GRANT OF PATENT INTENDED
EP12738060

DARUNAVIR COMBINATION FORMULATIONS

IPC classification:
A61K 9/16, A61K 9/20, A61K 31/34, A61K 31/5377, A61P 31/18
Applicant:
Janssen Research & Development Ireland
Applicant:
Gilead Sciences Inc
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Agent:
Frank F.R. Daelemans, Johnson & Johnson Belgium
Status:
GRANT OF PATENT INTENDED
EP12732668

DARUNAVIR FORMULATIONS

IPC classification:
A61K 9/16, A61K 9/20, A61K 31/34, A61P 31/18
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Agent:
Frank F.R. Daelemans, Johnson & Johnson Belgium
Status:
PATENT GRANTED
EP12784574

PURINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS

IPC classification:
A61K 31/522, A61P 31/12, C07D 473/34, C07D 519/00
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
EXAMINATION IN PROGRESS
EP12809772

HIV MEMBRANE FUSION INHIBITORS

IPC classification:
C07K 14/005, C07K 14/16
Applicant:
Pepscan Systems BV
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
GRANT OF PATENT INTENDED
EP12810312

QUINAZOLINONE DERIVATIVES AS HCV INHIBITORS

IPC classification:
A61K 31/517, A61P 31/12, C07D 403/14, C07D 491/113
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Agent:
Frank F.R. Daelemans, Johnson & Johnson Belgium
Status:
PATENT GRANTED
EP12810310

HETERO-BICYCLIC DERIVATIVES AS HCV INHIBITORS

IPC classification:
A61K 31/4412, A61K 31/506, A61K 31/513, A61K 31/527, A61P 31/14, C07D 401/14, C07D 403/14, C07D 491/10
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Agent:
Frank F.R. Daelemans, Johnson & Johnson Belgium
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13703055

PIPERIDINO-PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS

IPC classification:
A61K 31/519, A61P 31/00, C07D 471/04
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Agent:
Frank F.R. Daelemans, Johnson & Johnson Belgium
Status:
EXAMINATION IN PROGRESS
EP13722334

POLYINOSINIC-POLYCYTIDYLIC ACID (POLY (I:C)) FORMULATIONS FOR THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS

IPC classification:
A61K 9/00, A61K 9/16, A61K 31/713, A61K 47/24, A61K 47/36, A61K 47/38, A61P 11/00, A61P 31/16
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
EXAMINATION IN PROGRESS
EP13727945

A METHOD FOR THE PREPARATION OF 3-AMINO-N-CYCLOPROPYL-2-HYDROXYL-HEXANAMIDE

IPC classification:
C07C 231/02
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13735321

MACROCYCLIC PURINES FOR THE TREATMENT OF VIRAL INFECTIONS

IPC classification:
A61K 31/52, A61P 31/00, C07D 487/16, C07D 498/16
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
PATENT GRANTED
EP13748289

ALKYLPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES

IPC classification:
A61K 31/505, A61K 31/506, A61P 31/00, A61P 35/00, C07D 239/48, C07D 401/06, C07D 409/06
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
EXAMINATION IN PROGRESS
EP13762816

POTENTIOMETRIC SENSOR

IPC classification:
B01D 69/12, B01D 69/14, C07F 9/10, C12Q 1/00, G01N 27/333, G01N 33/543
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
GRANT OF PATENT INTENDED
EP13779156

ACYLAMINOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES

IPC classification:
A61K 31/505, A61P 31/12, C07D 213/75, C07D 239/48
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, Janssen Pharmaceutica N.V.
Status:
EXAMINATION IN PROGRESS
EP13779766

PYRROLO[3,2-D]PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER DISEASES

IPC classification:
A61K 31/519, A61P 29/00, A61P 31/12, A61P 37/00, C07D 487/04
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
EXAMINATION IN PROGRESS
EP13789821

HETEROCYCLIC SUBSTITUTED 2-AMINO-QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS

IPC classification:
A61K 31/505, A61P 31/12, C07D 239/95
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, Janssen Pharmaceutica N.V.
Status:
EXAMINATION IN PROGRESS
EP14705356

2-AMINOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS

IPC classification:
A61K 31/505, A61P 31/12, C07D 239/48
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
GRANT OF PATENT INTENDED
EP14717689

MACROCYCLIC DEAZA-PURINONES FOR THE TREATMENT OF VIRAL INFECTIONS

IPC classification:
A61K 31/522, C07D 473/00
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP14718588

QUASISPECIES ANALYSIS OF JC VIRUS DNA PRESENT IN URINE OF HEALTHY SUBJECTS

IPC classification:
C12Q 1/68, C12Q 1/70
Applicant:
Janssen Diagnostics BVBA
Agent:
Frank F.R. Daelemans, Janssen Pharmaceutica N.V.
Status:
EXAMINATION IN PROGRESS
EP14725996

PYRIDONE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES

IPC classification:
A61K 31/506, C07D 401/06
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, Janssen Pharmaceutica N.V.
Status:
GRANT OF PATENT INTENDED
EP14744834

THIENO[3,2-d]PYRIMIDINES DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS

IPC classification:
A61K 31/519, A61P 37/04, C07D 495/04
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, Janssen Pharmaceutica N.V.
Status:
GRANT OF PATENT INTENDED
EP14738751

PYRROLO [3,2-D] PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER DISEASES

IPC classification:
A61K 31/519, A61P 31/12, C07D 487/04
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
The patent has been granted
EP11711573

MACROCYCLIC INTEGRASE INHIBITORS

IPC classification:
A61K 31/529, A61P 31/18, C07D 487/18, C07D 498/18, C07D 515/18
Applicant:
Janssen Research & Development Ireland
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14793168

POLYLNOSINIC-POLYCYTIDYLIC ACID (POLY (I:C)) FORMULATIONS FOR THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS

IPC classification:
A61K 9/16, A61K 31/787, A61K 47/26, A61K 47/36, A61K 47/38, A61P 31/16
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
EXAMINATION REQUESTED
EP15706426

IDENTIFICATION OF JC VIRAL EPITOPES BY CYTOTOXIC T LYMPHOCYTES IN HEALTHY INDIVIDUALS AND THEIR USE IN ASSAYS

IPC classification:
G01N 33/569, G01N 33/68
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
EXAMINATION REQUESTED
EP15720010

USE OF A HIV DERIVED ACCESSORY PROTEIN FOR THE REACTIVATION OF LATENT HIV

IPC classification:
A61K 38/16, C07K 14/16
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
EXAMINATION REQUESTED
EP15750365

INDOLES FOR USE IN INFLUENZA VIRUS INFECTION

IPC classification:
A61P 31/16, C07D 401/14, C07D 403/14
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
EXAMINATION REQUESTED
EP15745483

COMPACTED SOLID DOSAGE FORM

IPC classification:
A61K 9/20, A61K 39/395
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
EXAMINATION REQUESTED
EP15760159

PYRROLOPYRIMIDINES FOR USE IN INFLUENZA VIRUS INFECTION

IPC classification:
A61K 31/519, A61P 31/16, C07D 487/04
Applicant:
Janssen Sciences Ireland UC
Agent:
Frank F.R. Daelemans, J&J Patent Law Department
Status:
Request for examination was made

Please Sign in to use this feature